CA3226259A1 - Peptide compositions capable of binding lanthionine synthetase c-like protein (lancl) and uses thereof - Google Patents
Peptide compositions capable of binding lanthionine synthetase c-like protein (lancl) and uses thereof Download PDFInfo
- Publication number
- CA3226259A1 CA3226259A1 CA3226259A CA3226259A CA3226259A1 CA 3226259 A1 CA3226259 A1 CA 3226259A1 CA 3226259 A CA3226259 A CA 3226259A CA 3226259 A CA3226259 A CA 3226259A CA 3226259 A1 CA3226259 A1 CA 3226259A1
- Authority
- CA
- Canada
- Prior art keywords
- peptide
- group
- amino acid
- condition
- disease
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0815—Tripeptides with the first amino acid being basic
- C07K5/0817—Tripeptides with the first amino acid being basic the first amino acid being Arg
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1019—Tetrapeptides with the first amino acid being basic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/64—Cyclic peptides containing only normal peptide links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Virology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Pulmonology (AREA)
- Communicable Diseases (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2021902267A AU2021902267A0 (en) | 2021-07-23 | Compositions and uses thereof | |
| AU2021902267 | 2021-07-23 | ||
| PCT/AU2022/050778 WO2023000038A1 (en) | 2021-07-23 | 2022-07-22 | Peptide compositions capable of binding lanthionine synthetase c-like protein (lancl) and uses thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA3226259A1 true CA3226259A1 (en) | 2023-01-26 |
Family
ID=84980448
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA3226259A Pending CA3226259A1 (en) | 2021-07-23 | 2022-07-22 | Peptide compositions capable of binding lanthionine synthetase c-like protein (lancl) and uses thereof |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20250263435A1 (cg-RX-API-DMAC10.html) |
| EP (1) | EP4373509A4 (cg-RX-API-DMAC10.html) |
| JP (1) | JP2024525959A (cg-RX-API-DMAC10.html) |
| KR (1) | KR20240036634A (cg-RX-API-DMAC10.html) |
| CN (1) | CN117813105A (cg-RX-API-DMAC10.html) |
| AU (1) | AU2022316237A1 (cg-RX-API-DMAC10.html) |
| CA (1) | CA3226259A1 (cg-RX-API-DMAC10.html) |
| WO (1) | WO2023000038A1 (cg-RX-API-DMAC10.html) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7751583B2 (ja) * | 2019-12-27 | 2025-10-08 | ラテラル、アイピー、プロプライエタリー、リミテッド | 環状ペプチド受容体ランチオニンシンテターゼc様タンパク質(lancl)及びその使用 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6638911B1 (en) * | 1998-05-05 | 2003-10-28 | Adherex Technologies Inc. | Compounds and methods for modulating desmosomal cadherin-mediated functions |
| AUPQ981700A0 (en) * | 2000-09-01 | 2000-09-28 | Metabolic Pharmaceuticals Limited | Product and method for control of obesity |
| WO2007068039A1 (en) * | 2005-12-12 | 2007-06-21 | Metabolic Pharmaceuticals Limited | Treatment of weight gain in estrogen deficient mammals |
| WO2009013621A2 (en) * | 2007-05-30 | 2009-01-29 | Auckland Uniservices Limited | Inhibitors for growth hormone and related hormones, and methods of use thereof |
| WO2009094172A2 (en) * | 2008-01-22 | 2009-07-30 | Araim Pharmaceuticals, Inc. | Tissue protective peptides and peptide analogs for preventing and treating diseases and disorders associated with tissue damage |
| CA3032944A1 (en) * | 2016-08-05 | 2018-02-08 | Sera Prognostics, Inc. | Biomarkers for predicting preterm birth in a pregnant female exposed to progestogens |
| CN110546157A (zh) * | 2017-02-22 | 2019-12-06 | 健康之语公司 | 筛查感染的方法 |
| WO2019136528A1 (en) * | 2018-01-15 | 2019-07-18 | Lateral IP Pty Ltd | Peptides and uses thereof |
| WO2019183686A1 (en) * | 2018-03-29 | 2019-10-03 | Lateral IP Pty Ltd | Cyclic peptides and uses thereof |
| US11149256B2 (en) * | 2018-09-26 | 2021-10-19 | California Institute Of Technology | Adeno-associated virus compositions for targeted gene therapy |
| EP3671210A1 (en) * | 2018-12-21 | 2020-06-24 | Biosystems International KFT | Lung cancer protein epitomic biomarkers |
| JP7751583B2 (ja) * | 2019-12-27 | 2025-10-08 | ラテラル、アイピー、プロプライエタリー、リミテッド | 環状ペプチド受容体ランチオニンシンテターゼc様タンパク質(lancl)及びその使用 |
| RU2731919C1 (ru) * | 2020-03-25 | 2020-09-09 | Федеральное государственное автономное образовательное учреждение высшего образования "Белгородский государственный национальный исследовательский университет" (НИУ "БелГУ") | Способ коррекции микроциркуляции в плаценте пептидом, имитирующим альфа-спираль B эритропоэтина, при ADMA-подобной модели преэклампсии |
| RU2751964C1 (ru) * | 2021-02-17 | 2021-07-21 | Федеральное государственное автономное образовательное учреждение высшего образования "Белгородский государственный национальный исследовательский университет" (НИУ "БелГУ") | Способ снижения агрегационной способности тромбоцитов |
-
2022
- 2022-07-22 KR KR1020247005610A patent/KR20240036634A/ko active Pending
- 2022-07-22 US US18/291,004 patent/US20250263435A1/en active Pending
- 2022-07-22 JP JP2024504021A patent/JP2024525959A/ja active Pending
- 2022-07-22 WO PCT/AU2022/050778 patent/WO2023000038A1/en not_active Ceased
- 2022-07-22 CA CA3226259A patent/CA3226259A1/en active Pending
- 2022-07-22 AU AU2022316237A patent/AU2022316237A1/en active Pending
- 2022-07-22 CN CN202280051738.3A patent/CN117813105A/zh active Pending
- 2022-07-22 EP EP22844731.4A patent/EP4373509A4/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CN117813105A (zh) | 2024-04-02 |
| AU2022316237A1 (en) | 2024-02-01 |
| US20250263435A1 (en) | 2025-08-21 |
| WO2023000038A1 (en) | 2023-01-26 |
| JP2024525959A (ja) | 2024-07-12 |
| KR20240036634A (ko) | 2024-03-20 |
| EP4373509A4 (en) | 2025-10-29 |
| EP4373509A1 (en) | 2024-05-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11723949B2 (en) | Modulators of complement activity | |
| US11752190B2 (en) | Modulators of complement activity | |
| US20210000927A1 (en) | Modulators of complement activity | |
| KR20200003229A (ko) | 심부전의 치료를 위한 합성 아펠린 모방체 | |
| JP2015517484A (ja) | ペプチドの塩酸塩及び他のペプチドとの併用によるその免疫治療用途 | |
| US20250263435A1 (en) | Peptide compositions capable of binding lanthionine synthetase c-like protein (lancl) and uses thereof | |
| US12492223B2 (en) | Peptide compositions capable of binding lanthionine synthetase C-like protein (LanCl) and uses thereof | |
| US20230256059A1 (en) | Compositions for treating respiratory tract infection and uses thereof | |
| CN111936508A (zh) | 环肽及其用途 | |
| CN102123725A (zh) | 用作精神刺激剂的Opiorphin | |
| US20250255934A1 (en) | Compositions for treating inflammatory airway disease and uses thereof | |
| US10981956B2 (en) | Neuroprotective peptide | |
| CA3047320A1 (en) | Methods of administering hepcidin | |
| US10660934B2 (en) | Neuroprotective peptide | |
| HK40031446B (en) | Modulators of complement activity | |
| HK40031446A (en) | Modulators of complement activity |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| W00 | Other event occurred |
Free format text: ST27 STATUS EVENT CODE: A-1-1-W10-W00-W100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: LETTER SENT Effective date: 20260109 |
|
| U13 | Renewal or maintenance fee not paid |
Free format text: ST27 STATUS EVENT CODE: N-1-6-U10-U13-U300 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: DEEMED ABANDONED - FAILURE TO RESPOND TO MAINTENANCE FEE NOTICE Effective date: 20260309 |